Patients with Right-Sided Primary (RSP) tumors treated with SIRT using SIR-Spheres® Y-90 resin microspheres plus mFOLFOX 6 also showed a trend towards improved PFS compared with those who received mFOLFOX-6 alone (median 10.8 vs. 8.7 months, respectively; HR: 0.73 [95% CI: 0.53–1.01] p=0.056).
Gibbs P et al. Clin Col Cancer 2018; 17: e617-e629